Form 4: CEL-SCI Corp: Chief Scientific Officer Eyal Talor Acquires 182,000 Stock Options

Eyal Talor, Chief Scientific Officer of CEL-SCI Corp, reports the acquisition of 182,000 stock options.

Summary

• On April 19, 2024, Eyal Talor, the Chief Scientific Officer of CEL-SCI Corp, acquired 182,000 stock options.
• The options have an exercise price of $1.50.
• The options vest in three equal annual installments starting one year after the grant date.
• The expiration date for these options is April 18, 2034.
• Following this transaction, Eyal Talor directly owns 1,998,646 shares of common stock.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a routine disclosure of stock option grants. The impact on the company's valuation is likely minimal unless it signals a larger trend or change in executive compensation strategy.

Positives

• The acquisition of stock options by a key executive could be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This is a standard SEC Form 4 filing, reporting a change in beneficial ownership by a company insider. Such filings are common and provide transparency into the trading activities of company executives.

Stakeholder Impact

• The granting of stock options to the Chief Scientific Officer may align his interests with those of the shareholders, incentivizing him to work towards increasing the company's value.

Key Dates